Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 09:45 am Sale | 2023-12-31 | 13G | iTeos Therapeutics, Inc. ITOS | BIOTECHNOLOGY VALUE FUND L P | 1,259,476 3.500% | -551,359 (-30.45%) | Filing History |
| 2024-02-14 09:43 am Purchase | 2023-12-31 | 13G | Janux Therapeutics, Inc. JANX | BIOTECHNOLOGY VALUE FUND L P | 4,579,818 9.900% | 472,873 (+11.51%) | Filing History |
| 2024-02-14 09:41 am Sale | 2023-12-31 | 13G | Jasper Therapeutics, Inc. JSPR | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -990,000 (Position Closed) | Filing History |
| 2024-02-14 09:39 am Purchase | 2023-12-31 | 13G | Kura Oncology, Inc. KURA | BIOTECHNOLOGY VALUE FUND L P | 7,373,228 9.900% | 3,572,245 (+93.98%) | Filing History |
| 2024-02-14 09:37 am Purchase | 2023-12-31 | 13G | Lexicon Pharmaceuticals, Inc. LXRX | BIOTECHNOLOGY VALUE FUND L P | 24,435,632 9.980% | 8,286,453 (+51.31%) | Filing History |
| 2024-02-14 09:35 am Sale | 2023-12-31 | 13G | Merus N.V. MRUS | BIOTECHNOLOGY VALUE FUND L P | 2,752,420 4.800% | -226,000 (-7.59%) | Filing History |
| 2024-02-14 09:33 am Purchase | 2023-12-31 | 13G | Molecular Templates, Inc. MTEM | BIOTECHNOLOGY VALUE FUND L P | 537,426 9.990% | 537,426 (New Position) | Filing History |
| 2024-02-14 09:31 am Purchase | 2023-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | BIOTECHNOLOGY VALUE FUND L P | 5,763,948 9.990% | 738,048 (+14.68%) | Filing History |
| 2024-02-14 09:28 am Sale | 2023-12-31 | 13G | Pyxis Oncology, Inc. PYXS | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -2,938,851 (Position Closed) | Filing History |
| 2024-02-14 09:26 am Sale | 2023-12-31 | 13G | Revolution Medicines, Inc. RVMD | BIOTECHNOLOGY VALUE FUND L P | 5,981,212 3.600% | -1,574,376 (-20.84%) | Filing History |
| 2024-02-14 09:24 am Purchase | 2023-12-31 | 13G | Tyra Biosciences, Inc. TYRA | BIOTECHNOLOGY VALUE FUND L P | 2,739,595 6.400% | 267,268 (+10.81%) | Filing History |
| 2024-02-14 09:22 am Sale | 2023-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -2,302,094 (Position Closed) | Filing History |
| 2024-02-14 09:20 am Purchase | 2023-12-31 | 13G | Verastem, Inc. VSTM | BIOTECHNOLOGY VALUE FUND L P | 2,617,402 9.990% | 2,617,402 (New Position) | Filing History |
| 2024-01-29 5:13 pm Sale | 2024-01-25 | 13D | Rain Enhancement Technologies Holdco Inc RAIN | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -3,526,729 (Position Closed) | Filing History |
| 2024-01-29 4:31 pm Unchanged | 2023-03-29 | 13G | GlycoMimetics, Inc. GLYC | BIOTECHNOLOGY VALUE FUND L P | 95,443 14.800% | 0 (Unchanged) | Filing History |
| 2024-01-18 4:32 pm Purchase | 2024-01-16 | 13G | Allakos Inc. ALLK | BIOTECHNOLOGY VALUE FUND L P | 16,552,417 18.900% | 8,000,000 (+93.54%) | Filing History |
| 2024-01-18 4:29 pm Purchase | 2023-12-31 | 13G | Allakos Inc. ALLK | BIOTECHNOLOGY VALUE FUND L P | 8,552,417 9.800% | 3,545,496 (+70.81%) | Filing History |
| 2024-01-18 4:18 pm Purchase | 2024-01-08 | 13G | Immunic, Inc. IMUX | BIOTECHNOLOGY VALUE FUND L P | 8,902,972 9.900% | 8,902,972 (New Position) | Filing History |
| 2024-01-16 5:22 pm Purchase | 2024-01-11 | 13D | XOMA Corporation XOMA | BIOTECHNOLOGY VALUE FUND L P | 3,633,743 31.600% | 103,200 (+2.92%) | Filing History |
| 2024-01-09 4:45 pm Purchase | 2024-01-05 | 13D | Kymera Therapeutics, Inc. KYMR | BIOTECHNOLOGY VALUE FUND L P | 5,831,171 9.990% | 1,138,567 (+24.26%) | Filing History |